Načítá se...
Advances in treatment for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation
The majority of newly diagnosed multiple myeloma patients are over 65 years and/or physically unfit, and, therefore, are not eligible for standard treatment with high-dose chemotherapy and stem cell transplantation. The treatment goals in these patients should be to ensure improvement in disease man...
Uloženo v:
| Vydáno v: | Leukemia Suppl |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4851189/ https://ncbi.nlm.nih.gov/pubmed/27175257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leusup.2013.5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|